Cover Image
市場調查報告書

美國的矯正器具、義肢 (O&P) 市場:分析與預測

Orthotic and Prosthetic (O&P) Devices - US Analysis and Market Forecasts

出版商 GlobalData 商品編碼 357842
出版日期 內容資訊 英文 136 Pages
訂單完成後即時交付
價格
Back to Top
美國的矯正器具、義肢 (O&P) 市場:分析與預測 Orthotic and Prosthetic (O&P) Devices - US Analysis and Market Forecasts
出版日期: 2015年08月01日 內容資訊: 英文 136 Pages
簡介

隨著全球人口的老年人增加,及各種疾病 (糖尿病,血管疾病,骨關節炎等) 的患者數的增加,在全球各國整形外科用矯正器具、義肢的需求擴大著。還有非侵入性的治療器具 (骨折等用) ,及術後的復建設備的矯正器具的需求也擴大著。為了改善患者的舒適性的技術開發也有所發展,那也成為市場成長的原因之一。

本報告提供美國的矯正器具及義肢 (含O&P、固定裝置、支撐器具的) 的市場相關分析,治療方法、相關疾病概要和基本的市場結構,已上市/臨床實驗中主要的產品的概要,全球及各地區、主要國家的市場趨勢與今後的預測,主要企業簡介等相關調查與考察。

第1章 目錄

第2章 簡介

第3章 產業概要

  • 概況
  • 治療的趨勢
    • 各國趨勢
  • 市場進入
    • 購買意願決策
  • 品牌忠誠
  • 普及情形
  • 法規趨勢:美國的情況
  • 醫療費償付制度
  • 產品的回收 (共3件)
  • 企業合併、收購 (M&A) (共10件)
  • 經濟上的影響
    • 間接的影響
    • 直接性影響

第4章 未滿足需求

  • 上肢用義肢的需求擴大
  • 矯正器具、義肢的自訂生產花費的時間縮短
  • 插座式義足
  • 患者的需求變化
  • 交換時及醫療費償付上的限制
  • 矯正器具、義肢專家的不足

第5章 市場促進、阻礙因素與市場機會

  • 推動因素:負傷者
  • 推動因素:全球人口的高齡化
  • 推動因素:非侵入性、可動式治療方法的矯正器具
  • 推動因素:糖尿病、血管疾病
  • 對阻礙因素:醫療設備的物品稅
  • 阻礙因素:現有的矯正器具、義肢市場
  • 阻礙因素:醫療費償付的限制
  • 市場機會:積極型的下肢用義肢
  • 市場機會:CAD、CAM的有效利用
  • 市場機會:3D列印
  • 市場機會:骨結合

第6章 競爭力的評估

  • 概要
  • 技術、產品概要
  • 產品系列 (共13家公司)
  • 各類型產品的SWOT分析
    • 矯正器具
    • 義肢

第7章 開發中產品的評估

  • 矯正器具產品
  • 義肢產品

第8章 值得注意的臨床實驗 (共9件)

第9章 現在、未來市場參與企業

  • 概要
  • 企業策略的趨勢
  • Bauerfeind AG
    • 概要
    • 產品系列的評估
    • SWOT分析
  • Breg, Inc.
  • BSN Medical GmbH
  • DeRoyal Industries, Inc.
  • DJO Global, Inc.
  • Endolite (Blatchford)
  • Hanger, Inc.
  • Medi GmbH & Co. KG
  • Ossur hf.
  • Ottobock HealthCare GmbH
  • Spinal Technology, Inc.
  • Touch Bionics Limited
  • WillowWood

第10章 市場競爭的策略性評估

  • 矯正器具:企業佔有率分析
  • 義肢:企業佔有率分析

第11章 市場未來展望:各地區

  • 矯正器具
  • 義肢

第12章 附錄

圖表一覽

目錄
Product Code: GDME1158CFR

The global orthotics and prosthetics (O&P) market, which includes braces and supports and prosthetic devices, is an expansive market covering a broad range of indications. Braces and supports, external devices that provide support to joints and weakened musculoskeletal groups to facilitate function and healing, are utilized prominently in osteoarthritis management; fracture, sprain, strain, and tear treatment; and prophylactic sports use. For this report, prosthesis use is focused on a single indication: extremity amputation.

The growing global aging population and subsequent rise in the prevalence of diseases that primarily affect the elderly, including diabetes, vascular disease, and osteoarthritis, as well as the increase in adoption of braces and supports for non-invasive treatment, particularly in fracture management and post-operative rehabilitation, are expected to drive growth in the O&P market. Emerging O&P technologies focus on improving patient comfort and functionality to facilitate increased product adoption.

This report examines O&P device adoption and challenges faced by current competitors in the US. The analysis also identifies unmet needs in the market, specifies the major drivers and barriers to device adoption, and provides an understanding of physician perception and outlook with an overall emphasis on current and future industry trends in the US.

Highlights

Key Questions Answered

  • What is the current and future O&P market outlook in the US market? What trends are affecting this O&P market?
  • Which are the key, high growth markets that O&P manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?
  • What are the unmet needs with O&P products currently on the market? How will emerging technologies fulfill these unmet needs?
  • What clinical factors and technical specifications influence a physician to use one type of brace or prosthetic device over another? What is physician perception and market outlook of O&P?
  • What are the challenges and complications of O&P that have hindered widespread adoption?
  • With developing the next-generation of O&P products, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global O&P market?

Scope

  • Annualized total O&P market revenue by type of device, direct and indirect costs of disease, procedure trends, and market outlooks for the US through 2021.
  • Key topics covered include strategic competitor assessment, market characterization, identification of unmet needs, reimbursement and regulatory considerations, evaluating market access in the US, and implications of the emerging technologies on the market.
  • Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and O&P products in development.
  • Analysis of the current and future market competition in the US O&P market. Insightful review of the key industry drivers, opportunities, barriers and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

  • "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading orthopedic surgeons and O&P practitioners from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Overview
  • 3.2. Procedure Trends
    • 3.2.1. By Country
  • 3.3. Market Access
    • 3.3.1. Purchasing Decisions
  • 3.4. Brand Loyalty
  • 3.5. Adoption
  • 3.6. Regulation
    • 3.6.1. US
  • 3.7. Reimbursement
    • 3.7.1. US
  • 3.8. Product Recalls
    • 3.8.1. Ability Dynamics Recalls Rush81 Prosthetic Foot (June 2014)
    • 3.8.2. Zimmer Recalls Drop-Lok Knee Brace, Cartilage Knee Brace, Hinged Knee Support, and Tennis Elbow Support (April 2014)
    • 3.8.3. Ossur Recalls Symbionic Leg (February 2014)
  • 3.9. Mergers and Acquisitions
    • 3.9.1. Ottobock Entered Licensing Agreement with Ekso Bionics (November 2014)
    • 3.9.2. Breg to Merge with United Orthopedic Group (October 2014)
    • 3.9.3. Ottobock to Distribute Artec's 3D Scanners (July 2014)
    • 3.9.4. Hanger Acquired Prosthetic Laboratories of Rochester (June 2014)
    • 3.9.5. Hanger Acquired Four Patient Care Companies (August 2013)
    • 3.9.6. Ossur Acquired TeamOlmed for $47m (May 2013)
    • 3.9.7. DJO Global Acquired Exos (December 2012)
    • 3.9.8. Hanger Acquired Two Patient Care Companies (December 2012)
    • 3.9.9. Hanger Acquired Five Companies (August 2011)
    • 3.9.10. Thuasne Acquired Townsend Design (January 2011)
  • 3.10. Economic Impact
    • 3.10.1. Indirect Costs
    • 3.10.2. Direct Costs

4. Unmet Needs

  • 4.1. Need for More Upper Limb Prostheses
  • 4.2. Reducing Custom Orthosis and Prosthesis Production Timeline
  • 4.3. Lower Limb Prosthetic Socket Fit
  • 4.4. Changes in Patient Need
  • 4.5. Replacement and Reimbursement Limitations
  • 4.6. Shortage of Orthotic and Prosthetic Professionals

5. Market Drivers, Barriers, and Opportunities

  • 5.1. Driver: Combat Injuries
  • 5.2. Driver: Aging Global Population
  • 5.3. Driver: Orthoses Used as Non-invasive and Mobile Treatments
  • 5.4. Driver: Diabetes and Vascular Disease
  • 5.5. Barrier: Medical Device Excise Tax
  • 5.6. Barrier: Established Orthotics and Prosthetics Market
  • 5.7. Barrier: Restricted Reimbursement
  • 5.8. Opportunity: Active Lower Extremity Prostheses
  • 5.9. Opportunity: Computer Aided Design and Computer Aided Manufacture
  • 5.10. Opportunity: 3D Printing
  • 5.11. Opportunity: Osseointegration

6. Competitive Assessment

  • 6.1. Overview
  • 6.2. Technology and Product Offerings
  • 6.3. Product Portfolios
    • 6.3.1. Bauerfeind
    • 6.3.2. Breg
    • 6.3.3. BSN
    • 6.3.4. DeRoyal
    • 6.3.5. DJO
    • 6.3.6. Endolite (Blatchford)
    • 6.3.7. Hanger
    • 6.3.8. Medi
    • 6.3.9. Ossur
    • 6.3.10. Ottobock
    • 6.3.11. Spinal Tech
    • 6.3.12. Touch Bionics
    • 6.3.13. WillowWood
  • 6.4. Product Category SWOT Profiles
    • 6.4.1. Orthotics
    • 6.4.2. Prosthetics

7. Pipeline Assessment

  • 7.1. Orthotic Products
  • 7.2. Prosthetic Products

8. Clinical Trials to Watch

  • 8.1. Overview
  • 8.2. Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA)
  • 8.3. Use of Subtle Vibration to Improve Walking Ability by Lower Limb Amputees
  • 8.4. Home Study of an Advanced Upper Limb Prosthesis
  • 8.5. Feasibility of Implantable Myoelectric Sensors to Control Upper Limb Prostheses (IMES)
  • 8.6. The General Use of Robots in Stroke Recovery: The Anklebot
  • 8.7. Validation of a New Generation of Optimized Orthoses for Personalized Treatment of Adolescent Idiopathic Scoliosis
  • 8.8. Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
  • 8.9. Comparative Effectiveness Between Microprocessor Knees and Non-Microprocessor Knees (MPK-AOPA)

9. Current and Future Players

  • 9.1. Overview
  • 9.2. Trends in Corporate Strategy
  • 9.3. Bauerfeind AG
    • 9.3.1. Overview
    • 9.3.2. Portfolio Assessment

9.3.3. SWOT Analysis

  • 9.4. Breg, Inc.
    • 9.4.1. Overview
    • 9.4.2. Portfolio Assessment

9.4.3. SWOT Analysis

  • 9.5. BSN Medical GmbH
    • 9.5.1. Overview
    • 9.5.2. Portfolio Assessment

9.5.3. SWOT Analysis

  • 9.6. DeRoyal Industries, Inc.
    • 9.6.1. Overview
    • 9.6.2. Portfolio Assessment

9.6.3. SWOT Analysis

  • 9.7. DJO Global, Inc.
    • 9.7.1. Overview
    • 9.7.2. Portfolio Assessment

9.7.3. SWOT Analysis

  • 9.8. Endolite (Blatchford)
    • 9.8.1. Overview
    • 9.8.2. Portfolio Assessment

9.8.3. SWOT Analysis

  • 9.9. Hanger, Inc.
    • 9.9.1. Overview
    • 9.9.2. Portfolio Assessment

9.9.3. SWOT Analysis

  • 9.10. Medi GmbH & Co. KG
    • 9.10.1. Overview
    • 9.10.2. Portfolio Assessment

9.10.3. SWOT Analysis

  • 9.11. Ossur hf.
    • 9.11.1. Overview
    • 9.11.2. Portfolio Assessment

9.11.3. SWOT Analysis

  • 9.12. Ottobock HealthCare GmbH
    • 9.12.1. Overview
    • 9.12.2. Portfolio Assessment

9.12.3. SWOT Analysis

  • 9.13. Spinal Technology, Inc.
    • 9.13.1. Overview
    • 9.13.2. Portfolio Analysis

9.13.3. SWOT Analysis

  • 9.14. Touch Bionics Limited
    • 9.14.1. Overview
    • 9.14.2. Portfolio Assessment

9.14.3. SWOT Analysis

  • 9.15. WillowWood
    • 9.15.1. Overview
    • 9.15.2. Portfolio Assessment

9.15.3. SWOT Analysis

10. Strategic Competitive Assessment

  • 10.1. Orthotics: Company Market Share
    • 10.1.1. By Country
  • 10.2. Prosthetics: Company Market Share
    • 10.2.1. By Country

11. Market Outlooks by Geography

  • 11.1. Orthotics
    • 11.1.1. US
  • 11.2. Prosthetics
    • 11.2.1. US

12. Appendix

  • 12.1. Bibliography
  • 12.2. Abbreviations
  • 12.3. Report Methodology
    • 12.3.1. Overview
    • 12.3.2. Coverage
    • 12.3.3. Secondary Research
  • 12.4. Forecasting Methodology
  • 12.5. Physicians and Specialists Included in This Study
    • 12.5.1. Key Opinion Leaders
  • 12.6. Primary Research - Prescriber Survey
  • 12.7. About the Authors
    • 12.7.1. Analysts
    • 12.7.2. Global Head of Healthcare
  • 12.8. About GlobalData
  • 12.9. Disclaimer

List of Tables

  • Table 1: Medicare ICD-9 Codes and DRG codes for Common Orthotic and Prosthetic Needs
  • Table 2: HCPCS Codes for Common Orthotic and Prosthetic Devices, 2015
  • Table 3: Mergers and Acquisitions (2011-2014)
  • Table 4: Bauerfeind's Orthotics Portfolio
  • Table 5: Breg's Orthotics Portfolio
  • Table 6: Bledsoe Brace Systems' Orthotics Portfolio
  • Table 7: BSN Medical's Orthotics Portfolio
  • Table 8: DeRoyal's Orthotics Portfolio
  • Table 9: DJO's Orthotics Portfolio
  • Table 10: Endolite's Prosthetics Portfolio
  • Table 11: Hanger's Orthotics Portfolio
  • Table 12: Medi's Orthotics and Prosthetics Portfolio
  • Table 13: Ossur's Orthotics and Prosthetics Portfolio
  • Table 14: Ottobock's Orthotics and Prosthetics Portfolio
  • Table 15: Spinal Tech's Orthotics Portfolio
  • Table 16: Touch Bionics' Prosthetics Portfolio
  • Table 17: WillowWood's Prosthetics Portfolio
  • Table 18: SWOT Analysis - Custom-Fabricated Orthoses
  • Table 19: SWOT Analysis - Off-the-Shelf Orthoses
  • Table 20: SWOT Analysis - Active Upper Extremity Prostheses
  • Table 21: SWOT Analysis - Passive Upper Extremity Prostheses
  • Table 22: SWOT Analysis - Mechanical Lower Limb Prostheses
  • Table 23: SWOT Analysis - Microprocessor Lower Limb Prostheses
  • Table 24: SWOT Analysis - Non-functional Lower Limb Prostheses
  • Table 25: Pipeline Products in the Global Orthotics Market, 2015
  • Table 26: Pipeline Products in the Global Prosthetics Market, 2015
  • Table 27: Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA)
  • Table 28: Use of Subtle Vibration to Improve Walking Ability by Lower Limb Amputees
  • Table 29: Home Study of an Advanced Upper Limb Prosthesis
  • Table 30: Feasibility of Implantable Myoelectric Sensors to Control Upper Limb Prostheses (IMES)
  • Table 31: The General Use of Robots in Stroke Recovery: The Anklebot
  • Table 32: Validation of a New Generation of Optimized Orthoses for Personalized Treatment of Adolescent Idiopathic Scoliosis
  • Table 33: Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
  • Table 34: Comparative Effectiveness Between Microprocessor Knees and Non-Microprocessor Knees (MPK-AOPA)
  • Table 35: Company Profile - Bauerfeind AG
  • Table 36: SWOT Analysis - Bauerfeind
  • Table 37: Company Profile - Breg, Inc.
  • Table 38: SWOT Analysis - Breg
  • Table 39: Company Profile - BSN Medical GmbH
  • Table 40: SWOT Analysis - BSN
  • Table 41: Company Profile - DeRoyal Industries, Inc.
  • Table 42: SWOT Analysis - DeRoyal
  • Table 43: Company Profile - DJO Global, Inc.
  • Table 44: SWOT Analysis - DJO
  • Table 45: Company Profile - Endolite
  • Table 46: SWOT Analysis - Endolite
  • Table 47: Company Profile - Hanger
  • Table 48: SWOT Analysis - Hanger
  • Table 49: Company Profile - Medi GmbH & Co. KG
  • Table 50: SWOT Analysis - Medi
  • Table 51: Company Profile - Ossur hf.
  • Table 52: SWOT Analysis - Ossur
  • Table 53: Company Profile - Ottobock HealthCare GmbH
  • Table 54: SWOT Analysis - Ottobock
  • Table 55: Company Profile - Spinal Technology, Inc.
  • Table 56: SWOT Analysis - Spinal Tech
  • Table 57: Company Profile - Touch Bionics Limited
  • Table 58: SWOT Analysis - Touch Bionics
  • Table 59: Company Profile - WillowWood
  • Table 60: SWOT Analysis - WillowWood
  • Table 61: US Market Value Forecast by Market Segment for Orthotics, $m, 2012-2021
  • Table 62: US Market Value Forecast by Market Segment for Prosthetics, $m, 2012-2021

List of Figures

  • Figure 1: US Procedure Volume Forecast by Market Segment, 2012-2021
  • Figure 2: US Company Market Shares for Orthotics, 2014
  • Figure 3: US Company Market Shares for Prosthetics, 2014
  • Figure 4: US Market Value Forecast by Market Segment for Orthotics, $m, 2012-2021
  • Figure 5: US Market Value Comparison by Market Segment for Orthotics, 2014 & 2021
  • Figure 6: US Market Value Forecast by Market Segment for Prosthetics, $m, 2012-2021
  • Figure 7: US Market Value Comparison by Market Segment for Prosthetics, 2014 & 2021
Back to Top